Infections Associated With the Use of Alemtuzumab

Samsung Medical Center

Status: Completed

Conditions: Patients Treated With Alemtuzumab

Study type: Observational

Funder types: Other

Identifiers

NCT01315457

2009-03-006

Details and patient eligibility

About

The aim of this study is to propose infection prophylaxis from Asian multinational retrospective analysis of infectious complications in patients who were treated with alemtuzumab

Enrollment: 182 patients

Sex: All

Ages: 15 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients received alemtuzumab as a treatment for hematologic malignancy ex. non-Hodgkin lymphoma Acute myeloid leukemia Aplastic anemia

Exclusion criteria

• Patients did not receive alemtuzumab

Trial design

182 participants in 1 patient group

Alemtuzumab

Description:

Patients treated with alemtuzumab